<?xml version="1.0" ?><!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st June 2018//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_180601.dtd"><PubmedArticleSet><PubmedArticle>    <MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM">        <PMID Version="1">30158869</PMID>        <DateRevised>            <Year>2018</Year>            <Month>09</Month>            <Day>02</Day>        </DateRevised>        <Article PubModel="Electronic-eCollection">            <Journal>                <ISSN IssnType="Print">1663-9812</ISSN>                <JournalIssue CitedMedium="Print">                    <Volume>9</Volume>                    <PubDate>                        <Year>2018</Year>                    </PubDate>                </JournalIssue>                <Title>Frontiers in pharmacology</Title>                <ISOAbbreviation>Front Pharmacol</ISOAbbreviation>            </Journal>            <ArticleTitle>Pathway-Based Drug Repositioning for Breast Cancer Molecular Subtypes.</ArticleTitle>            <Pagination>                <MedlinePgn>905</MedlinePgn>            </Pagination>            <ELocationID EIdType="doi" ValidYN="Y">10.3389/fphar.2018.00905</ELocationID>            <Abstract>                <AbstractText>Breast cancer is a major public health problem which treatment needs new pharmacological options. In the last decades, during the postgenomic era new theoretical and technological tools that give us novel and promising ways to address these problems have emerged. In this work, we integrate several tools that exploit disease-specific experimental transcriptomic results in addition to information from biological and pharmacological data bases obtaining a contextual prioritization of pathways and drugs in breast cancer subtypes. The usefulness of these results should be evaluated in terms of drug repurposing in each breast cancer molecular subtype therapy. In favor of breast cancer patients, this methodology could be further developed to provide personalized treatment schemes. The latter are particularly needed in those breast cancer subtypes with limited therapeutic options or those who have developed resistance to the current pharmacological schemes.</AbstractText>            </Abstract>            <AuthorList CompleteYN="Y">                <Author ValidYN="Y">                    <LastName>Mejía-Pedroza</LastName>                    <ForeName>Raúl A</ForeName>                    <Initials>RA</Initials>                    <AffiliationInfo>                        <Affiliation>Computational Genomics Division, National Institute of Genomic Medicine, Mexico City, Mexico.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Espinal-Enríquez</LastName>                    <ForeName>Jesús</ForeName>                    <Initials>J</Initials>                    <AffiliationInfo>                        <Affiliation>Computational Genomics Division, National Institute of Genomic Medicine, Mexico City, Mexico.</Affiliation>                    </AffiliationInfo>                    <AffiliationInfo>                        <Affiliation>Centro de Ciencias de la Complejidad, Universidad Nacional Autónoma de México, Mexico City, Mexico.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Hernández-Lemus</LastName>                    <ForeName>Enrique</ForeName>                    <Initials>E</Initials>                    <AffiliationInfo>                        <Affiliation>Computational Genomics Division, National Institute of Genomic Medicine, Mexico City, Mexico.</Affiliation>                    </AffiliationInfo>                    <AffiliationInfo>                        <Affiliation>Centro de Ciencias de la Complejidad, Universidad Nacional Autónoma de México, Mexico City, Mexico.</Affiliation>                    </AffiliationInfo>                </Author>            </AuthorList>            <Language>eng</Language>            <PublicationTypeList>                <PublicationType UI="D016428">Journal Article</PublicationType>            </PublicationTypeList>            <ArticleDate DateType="Electronic">                <Year>2018</Year>                <Month>08</Month>                <Day>15</Day>            </ArticleDate>        </Article>        <MedlineJournalInfo>            <Country>Switzerland</Country>            <MedlineTA>Front Pharmacol</MedlineTA>            <NlmUniqueID>101548923</NlmUniqueID>            <ISSNLinking>1663-9812</ISSNLinking>        </MedlineJournalInfo>        <CommentsCorrectionsList>            <CommentsCorrections RefType="Cites">                <RefSource>Int J Cancer. 2015 Mar 1;136(5):E359-86</RefSource>                <PMID Version="1">25220842</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Mol Cancer Ther. 2011 Aug;10(8):1460-9</RefSource>                <PMID Version="1">21690228</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Carcinog Mutagen. 2013;2013(Suppl 7):null</RefSource>                <PMID Version="1">27088047</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Ann Oncol. 2015 Aug;26(8):1533-46</RefSource>                <PMID Version="1">25939896</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Nucleic Acids Res. 2000 Jan 1;28(1):27-30</RefSource>                <PMID Version="1">10592173</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Front Physiol. 2015 Dec 17;6:383</RefSource>                <PMID Version="1">26733877</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Clin Oncol. 2009 Mar 10;27(8):1160-7</RefSource>                <PMID Version="1">19204204</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Mol Oncol. 2015 Aug;9(7):1471-83</RefSource>                <PMID Version="1">25963740</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Nucleic Acids Res. 2016 Jan 4;44(D1):D1036-44</RefSource>                <PMID Version="1">26531824</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cardiooncology. 2016;2:</RefSource>                <PMID Version="1">28133540</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Nucleic Acids Res. 2014 Jul;42(13):e107</RefSource>                <PMID Version="1">24970867</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cancer. 2017 Jun 1;123(11):1925-1934</RefSource>                <PMID Version="1">28117882</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cell. 2015 Oct 8;163(2):506-19</RefSource>                <PMID Version="1">26451490</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Genome Biol. 2004;5(10):R80</RefSource>                <PMID Version="1">15461798</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Sci Rep. 2017 Oct 19;7(1):13534</RefSource>                <PMID Version="1">29051564</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Nucleic Acids Res. 2010 Oct;38(18):e178</RefSource>                <PMID Version="1">20802226</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Natl Cancer Inst. 2014 Aug 19;106(8):null</RefSource>                <PMID Version="1">25139534</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Nucleic Acids Res. 2015 Apr 20;43(7):e47</RefSource>                <PMID Version="1">25605792</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Wiley Interdiscip Rev Syst Biol Med. 2010 Jan-Feb;2(1):3-22</RefSource>                <PMID Version="1">20836007</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Br J Clin Pharmacol. 2001 Oct;52(4):345-7</RefSource>                <PMID Version="1">11678777</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Breast. 2015 Nov;24 Suppl 2:S26-35</RefSource>                <PMID Version="1">26253814</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Nature. 2012 Apr 18;486(7403):346-52</RefSource>                <PMID Version="1">22522925</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Science. 2006 Sep 29;313(5795):1929-35</RefSource>                <PMID Version="1">17008526</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Proc Natl Acad Sci U S A. 2013 Apr 16;110(16):6388-93</RefSource>                <PMID Version="1">23547110</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Ann Oncol. 2015 Sep;26 Suppl 5:v8-30</RefSource>                <PMID Version="1">26314782</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cancers (Basel). 2010 May 28;2(2):1040-65</RefSource>                <PMID Version="1">24281106</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Genome Biol. 2014;15(12):550</RefSource>                <PMID Version="1">25516281</PMID>            </CommentsCorrections>        </CommentsCorrectionsList>        <KeywordList Owner="NOTNLM">            <Keyword MajorTopicYN="N">breast neoplasms</Keyword>            <Keyword MajorTopicYN="N">databases</Keyword>            <Keyword MajorTopicYN="N">drug repositioning</Keyword>            <Keyword MajorTopicYN="N">genetic</Keyword>            <Keyword MajorTopicYN="N">pathway analysis</Keyword>            <Keyword MajorTopicYN="N">personalized medicine</Keyword>            <Keyword MajorTopicYN="N">systems biology</Keyword>        </KeywordList>    </MedlineCitation>    <PubmedData>        <History>            <PubMedPubDate PubStatus="received">                <Year>2018</Year>                <Month>04</Month>                <Day>27</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="accepted">                <Year>2018</Year>                <Month>07</Month>                <Day>24</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="entrez">                <Year>2018</Year>                <Month>8</Month>                <Day>31</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="pubmed">                <Year>2018</Year>                <Month>8</Month>                <Day>31</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="medline">                <Year>2018</Year>                <Month>8</Month>                <Day>31</Day>                <Hour>6</Hour>                <Minute>1</Minute>            </PubMedPubDate>        </History>        <PublicationStatus>epublish</PublicationStatus>        <ArticleIdList>            <ArticleId IdType="pubmed">30158869</ArticleId>            <ArticleId IdType="doi">10.3389/fphar.2018.00905</ArticleId>            <ArticleId IdType="pmc">PMC6104565</ArticleId>        </ArticleIdList>    </PubmedData></PubmedArticle></PubmedArticleSet>